Stock Information
Repligen Corp (RGEN)
Ticker Symbol: RGEN
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $6,629.92 mil
Piotroski score: 5
PE Ratio: 143.7478
EPS (TTM): 0.8644
Revenue (TTM): $13.02 M
Dividend Yield: N/A%
ROE: 2.37%
Latest News
-
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Thu, May 7, 2026 11:30 AM
-
JP Morgan Maintains Overweight on Repligen, Lowers Price Target to $165
Wed, May 6, 2026 5:13 PM
-
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
Wed, May 6, 2026 3:50 PM
-
Barclays Maintains Overweight on Repligen, Raises Price Target to $160
Wed, May 6, 2026 11:34 AM
-
Repligen Reshapes Operations And China Reach As Valuation Signals Upside
Wed, May 6, 2026 3:18 AM
-
Repligen Q1 Earnings Call Highlights
Tue, May 5, 2026 8:20 PM
-
Repligen Corporation Q1 2026 Earnings Call Summary
Tue, May 5, 2026 4:52 PM
-
Repligen (RGEN) Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 3:52 PM
-
Repligen Corporation (RGEN) Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 2:41 PM
-
Repligen (RGEN) Q1 Earnings and Revenues Beat Estimates
Tue, May 5, 2026 1:15 PM
Key Financials
Financial data not available
